← Evidence map

TrialJournal of cystic fibrosis : official journal of the European Cystic Fibrosis Society2022

C-reactive protein (CRP) as a biomarker of pulmonary exacerbation presentation and treatment response.

D R VanDevanter et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.

21 papers cite it

2022
2023
2024
2025
2026
this paperpooled ittrialcites it

The trial

Full record →Abstract, authors, funding and every citing paper · PMID 34933824